CLINICAL_TRIALS
trial_result
· 2017-03-07
Clinical Trial Update: Memantine Augmentation in Obsessive-Compulsive Disorder [Phase 1, Phase 2]
Summary
A completed Phase 1/2 clinical trial evaluating memantine augmentation in obsessive-compulsive disorder, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-07